Gastrointestinal Cancer
📧 Sign up to get email alerts when something new happens for Gastrointestinal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-06Clinical Trial Update: A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC) [Phase 1]
The Phase 1 study of LCAR-G08 for advanced gastrointestinal tumors expressing guanylyl cyclase C has been terminated. No results are reporte…
-
CLINICAL_TRIALS withdrawal · 2026-01-23Clinical Trial Update: Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis [NA]
The clinical trial evaluating sleep disturbances in surgical patients with gastrointestinal cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-28Clinical Trial Update: Dyadic Text-Messaging Micro-Intervention [NA]
The sponsor indicates that the dyadic text-messaging micro-intervention trial has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-03Clinical Trial Update: Combined Neuromuscular Electrical Stimulation and Nutritional Support for Advanced Gastrointestinal Cancer Patients. [NA]
The clinical trial evaluating combined neuromuscular electrical stimulation and nutritional support for advanced gastrointestinal cancer pat…
-
CLINICAL_TRIALS withdrawal · 2024-06-10Clinical Trial Update: Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers [Phase 1, Phase 2]
Clinical trial update indicates a Phase 1/2 personalized immunotherapy study in adults with upper gastrointestinal tract cancers has been wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-05-08Clinical Trial Update: Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers [NA]
The clinical trial investigating electronic patient-reported outcomes in gastrointestinal cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-26Clinical Trial Update: Lenvatinib and Capecitabine in Patients With Advanced Malignancies [Phase 1]
A Phase 1 study of lenvatinib in combination with capecitabine for patients with advanced cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-03Clinical Trial Update: Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients [NA]
University of Michigan-sponsored trial Mobility and Activity Training (MAT) for older adults undergoing abdominal surgery has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2013-10-22Clinical Trial Update: A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer
A Phase III randomized trial comparing Mapisal to a urea hand-foot cream for preventing capecitabine-related hand-foot syndrome in patients …